Clinical Trial Update: Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma

View source ↗

Summary

This clinical trial update reports that recruitment is ongoing for a study evaluating zanubrutinib in patients with Waldenström's macroglobulinemia, chronic lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Follicular Lymphoma
• Marginal Zone Lymphoma
• Waldenström Macroglobulinemia

Drugs mentioned

• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: iOMEDICO AG | Conditions: Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia | Status: RECRUITING